We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 324 results
  1. High-risk pituitary adenomas and strategies for predicting response to treatment

    High-risk pituitary adenomas are aggressive. They show clinical and imaging features similar to those of carcinomas, including infiltration of the...

    George Kontogeorgos, Eleni Thodou, ... Ricardo V. Lloyd in Hormones
    Article 21 January 2022
  2. Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature

    Epithelioid inflammatory myofibroblastic sarcomas are an aggressive variant of inflammatory myofibroblastic tumor described primarily in the abdomen...

    Shefali Chopra, Nolan Maloney, Wei Lien Wang in Brain Tumor Pathology
    Article 06 November 2021
  3. Spezielle mesenchymale Tumoren der Kopf-Hals-Region: Neues aus der WHO 2022

    Similar to the approach adopted in the classification of tumors in other organs, a new feature of the current Word Health Organization (WHO)...

    Abbas Agaimy, Alessandro Franchi in Die Pathologie
    Article 07 June 2023
  4. Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus

    Neuroendocrine tumors of the thymus (TNET) are exceedingly rare neoplasms. Their histomorphology is identical to neuroendocrine tumors elsewhere in...

    Hanibal Bohnenberger, Philipp Ströbel in Virchows Archiv
    Article Open access 01 January 2021
  5. Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies

    There are no therapeutic predictive biomarkers or representative preclinical models for high-grade gastroenteropancreatic neuroendocrine neoplasms...

    Simon L. April-Monn, Philipp Kirchner, ... Aurel Perren in npj Precision Oncology
    Article Open access 01 March 2024
  6. Study on intracranial meningioma using PET ligand investigation during follow-up over years (SIMPLIFY)

    Purpose

    Radiologic follow-up of patients with a meningioma at the skull base or near the venous sinuses with magnetic resonance imaging (MRI) after...

    Hanne-Rinck Jeltema, Marnix R. Jansen, ... J. Marc C. van Dijk in Neuroradiology
    Article Open access 10 March 2021
  7. Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study

    Purpose

    To correlate somatostatin receptor (SSTR) and proliferative activity profile (SSTR2, SSTR5, Ki-67) at immunohistochemistry (IHC) with...

    Vittoria Rufini, Margherita Lorusso, ... Guido Rindi in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 08 June 2022
  8. Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia

    Objective

    Tumor-induced osteomalacia (TIO) is caused by typically small tumors that secrete fibroblast growth factor 23 (FGF23). As tumor resection is...

    Ayako Kato, Yuji Nakamoto, ... Kaori Togashi in Annals of Nuclear Medicine
    Article 13 February 2021
  9. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

    Clear cell meningioma represents an uncommon variant of meningioma that typically affects children and young adults. Although an enrichment of...

    Philipp Sievers, Martin Sill, ... Felix Sahm in Acta Neuropathologica
    Article Open access 14 December 2020
  10. In this issue

    Article 08 September 2021
  11. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications

    Somatostatin receptor 2 (SSTR2) expression has previously been documented in olfactory neuroblastoma (ONB). Here, we fully characterize SSTR2...

    Vincent Cracolici, Eric W. Wang, ... Raja R. Seethala in Head and Neck Pathology
    Article 30 April 2021
  12. Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly

    Purpose

    We previously showed the clinical characteristics of acromegaly with a paradoxical growth hormone (GH) response to oral glucose or...

    Yuto Mitsui, Kosuke Mukai, ... Iichiro Shimomura in Pituitary
    Article Open access 19 June 2024
  13. In this issue

    Article 11 September 2020
  14. Recurrence in acromegaly: two tertiary centers experience and review of the literature

    Background

    Recurrence of acromegaly after successful surgery is a rare event, but no clear data are reported in the literature about its recurrence...

    A. Cremaschi, E. Sala, ... G. Mantovani in Journal of Endocrinological Investigation
    Article Open access 19 March 2024
  15. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts

    Ectopic Cushing syndrome is a rare clinical disorder resulting from excessive adrenocorticotrophic hormone (ACTH) produced by non-pituitary...

    Abbas Agaimy, Atsuko Kasajima, ... Günter Klöppel in Virchows Archiv
    Article Open access 24 January 2023
  16. Histopathologische Diagnostik von soliden und zystischen Pankreasläsionen mit Hauptaugenmerk auf dem duktalen Adenokarzinom

    Pancreas pathology is constantly evolving and can present various challenges for pathologists. This paper is focused on providing helpful hints for...

    Irene Esposito, Aslihan Yavas, Lena Häberle in Die Pathologie
    Article 08 January 2024
  17. Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution

    Background

    Phosphaturic mesenchymal tumor (PMT) is a rare tumor that causes tumor-induced osteomalacia. Patients present with non-specific symptoms...

    Marcos R. Gonzalez, Neel Patel, ... Santiago A. Lozano-Calderon in Skeletal Radiology
    Article 13 February 2024
  18. Malignant gastrointestinal neuroectodermal tumor in head and neck: two challenging cases with diverse morphology and different considerations for differential diagnosis

    Malignant gastrointestinal neuroectodermal tumor (MGNET) is a sarcoma typically involving the gastrointestinal tract with neuroectodermal...

    Chien-Tzu Kuo, Yu-Chien Kao, ... Jen-Chieh Lee in Virchows Archiv
    Article 18 January 2022
  19. Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm–neuroendocrine tumor

    Recently, the term mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) has been proposed as an umbrella definition covering different possible...

    Marco Schiavo Lena, Maria Giulia Cangi, ... Claudio Doglioni in Virchows Archiv
    Article 01 October 2020
  20. Update on Histological Reporting Changes in Neuroendocrine Neoplasms

    Purpose of Review

    Classification and nomenclature of neuroendocrine neoplasms (NEN) have frequently changed over the last years. These changes reflect...

    Konstantin Bräutigam, Antonio Rodriguez-Calero, ... Aurel Perren in Current Oncology Reports
    Article Open access 14 April 2021
Did you find what you were looking for? Share feedback.